West and Vetter develop prefilled WFI syringe for drug reconstitution

West, a US-based global manufacturer of components and systems for injectable drug delivery, and Vetter, a German contract manufacturer of prefilled application systems, have introduced a WFI prefilled syringe for reconstituting lyophilised drug products.

West, a US-based global manufacturer of components and systems for injectable drug delivery, and Vetter, a German contract manufacturer of prefilled application systems, have introduced a WFI prefilled syringe for reconstituting lyophilised drug products.

The syringe features a plunger with West's FluroTec barrier film and Vetter's V-OVS tamper-evident closure, which includes a West tip cap. The film, developed by West's partner, Daikyo Seiko, provides an effective barrier against organic and inorganic extractables, which helps maintain the purity of the diluent.

"The Vetter/West WFI syringe combines the best of pharmaceutical components in a drug administration system that we believe customers will embrace," said Mike Schaefers, West's European vice president of marketing.

The V-OVS closure system consists of a tip cap, a Vetter Luer lock and a tamper-evident seal. The components are pre-assembled as a single part, which is mounted on the syringe barrel with a Luer-cone and Luer-groove. The integrity of the syringe system is maintained if the seal has not been broken.

The syringes are available with fill volumes between 0.5ml and 3.0ml. The glass syringe barrels are treated with baked silicone and are visually inspected to provide the highest quality levels.

Packaging options include individual blister packaging.

Vetter fills and sterilises the syringe at its facility in Langenargen, Germany. The syringes are supplied with regulatory documentation to meet the requirements of markets in Europe, Japan, North America and other countries.

Featured Companies

Vetter Pharma International (more information, website)